Related Experiment Video
Updated: Sep 25, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Amalgamation of Nanotechnology for Delivery of Bioactive Constituents in Solid Tumors
Rabea Parveen1,2, Sradhanjali Mohapatra2, Sayeed Ahmad2
1Department of Biosciences, Human Genetics Laboratory, Jamia Millia Islamia, New Delhi-110025, India.
Abstract:
Solid tumor is one of the highly prevalent cancers among humans and the treatment is often restricted by drug resistance to chemotherapeutics. One of the main reasons might be attributed to the limited penetration ability of drugs through tumor tissues due to heterogeneity within the tumor microenvironment. Over the recent years, so much research has been carried out for developing phytochemicals as cancer therapeutic agents. These are well-established as potential candidates for preventing and treating cancer, especially solid tumors, but have limited clinical applications due to their large molecular size, low bioavailability, stability, and target specificity, along with other side effects when used at high concentrations. There has been a widely proposed nano delivery system of bioactive constituents to overcome these obstacles. This nanostructured system might be able to potentiate the action of plant constituents, by reducing the side effects at a lesser dose with improved efficacy. Indeed, nanosystems can deliver the bioactive constituents at a specific site in the desired concentration and avoid undesired drug exposure to normal tissues. Furthermore, these nanoparticles demonstrate high differential absorption efficiency in the target cells over normal cells by preventing them from interacting prematurely with the biological environment, enhancing the cellular uptake and retention effect in disease tissues, while decreasing the toxicity. This review discusses various treatment stratagems used for the management of solid tumors with special emphasis on nanocarrier systems as a potential treatment strategy for herbal drugs. This also covers a wide list of plants that are used for the treatment of solid tumors and cancers along with their mechanisms of action and enlists various nanocarrier systems used for different phytoconstituents. This review gives a brief idea about different plants and their constituents exploited for their anticancer/antitumor potential along with several nanocarrier systems employed for the same and gives future directions to stress the nanotechnology platform as a valuable approach for the prevention and treatment of solid tumors.
Insights
Nanotechnology enhances phytochemicals for solid tumor treatment by improving drug delivery and reducing side effects. This approach offers a promising strategy for overcoming limitations of traditional cancer therapies.
Area of Science:
- Oncology and Nanomedicine: Focuses on the intersection of cancer treatment and nanotechnology for solid tumors.
Background:
- Solid tumors present treatment challenges due to drug resistance and poor drug penetration caused by tumor microenvironment heterogeneity.
- Phytochemicals show promise as anticancer agents but face limitations like poor bioavailability, stability, and target specificity.
- Existing treatments are often hampered by side effects and limited efficacy, necessitating novel therapeutic strategies.
Approach:
- This review explores nanocarrier systems as a strategy to deliver bioactive phytochemicals for solid tumor management.
- It discusses various plants and their constituents with anticancer potential, detailing their mechanisms of action.
- Various nanocarrier systems employed for delivering these phytoconstituents are also enumerated.
Key Points:
- Nanocarrier systems can potentiate the action of plant-derived compounds, improving efficacy and reducing side effects.
- Nanosystems enable targeted delivery of phytochemicals to tumor sites, enhancing cellular uptake and retention.
- Nanoparticles offer differential absorption, increasing efficacy in diseased tissues while minimizing toxicity to normal cells.
Conclusions:
- Nanotechnology presents a valuable platform for developing effective phytomedicines for solid tumor prevention and treatment.
- Targeted delivery via nanocarriers overcomes phytochemical limitations, paving the way for improved cancer therapies.
- Further research into nanotechnology-based approaches is crucial for advancing solid tumor management.

